MCL coexpression mm9:668: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:41, 17 September 2013
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr13:31898767..31898785,+ | p4@Foxc1 |
Mm9::chr13:99124189..99124205,+ | p1@Foxd1 |
Mm9::chr13:99124236..99124243,+ | p2@Foxd1 |
Mm9::chr13:99124729..99124745,+ | p@chr13:99124729..99124745 + |
Mm9::chr2:165420509..165420580,+ | p1@Eya2 |
Mm9::chr5:137463527..137463538,+ | p9@Plod3 |
Mm9::chr5:38215819..38215823,- | p1@Msx1 |
Mm9::chr6:72185396..72185413,- | p6@Atoh8 |
Mm9::chr8:123640063..123640077,+ | p1@Foxc2 |
Mm9::chr8:123640090..123640101,+ | p2@Foxc2 |
Mm9::chr9:98325725..98325749,+ | p@chr9:98325725..98325749 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0003007 | heart morphogenesis | 5.83960470390845e-05 |
GO:0008301 | DNA bending activity | 7.15673488729175e-05 |
GO:0048844 | artery morphogenesis | 7.15673488729175e-05 |
GO:0055010 | ventricular cardiac muscle morphogenesis | 7.15673488729175e-05 |
GO:0001945 | lymph vessel development | 7.15673488729175e-05 |
GO:0048341 | paraxial mesoderm formation | 7.5383323061609e-05 |
GO:0055008 | cardiac muscle morphogensis | 7.5383323061609e-05 |
GO:0001822 | kidney development | 7.5383323061609e-05 |
GO:0046620 | regulation of organ growth | 7.66010241537851e-05 |
GO:0001655 | urogenital system development | 7.66010241537851e-05 |
GO:0060038 | cardiac muscle cell proliferation | 7.70303049760186e-05 |
GO:0048644 | muscle morphogenesis | 7.70303049760186e-05 |
GO:0014855 | striated muscle cell proliferation | 7.70303049760186e-05 |
GO:0048340 | paraxial mesoderm morphogenesis | 9.19479537249385e-05 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 0.000116604844891553 |
GO:0035265 | organ growth | 0.000133418602801376 |
GO:0006366 | transcription from RNA polymerase II promoter | 0.000133418602801376 |
GO:0048339 | paraxial mesoderm development | 0.000133418602801376 |
GO:0035050 | embryonic heart tube development | 0.000133418602801376 |
GO:0033002 | muscle cell proliferation | 0.000133418602801376 |
GO:0043565 | sequence-specific DNA binding | 0.000133418602801376 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 0.000147771138511505 |
GO:0030199 | collagen fibril organization | 0.000156267844528636 |
GO:0001974 | blood vessel remodeling | 0.000156267844528636 |
GO:0048468 | cell development | 0.000175048166605948 |
GO:0043066 | negative regulation of apoptosis | 0.000198974838792371 |
GO:0043069 | negative regulation of programmed cell death | 0.00019941297764676 |
GO:0003705 | RNA polymerase II transcription factor activity, enhancer binding | 0.000217977795038277 |
GO:0007517 | muscle development | 0.000246504110865134 |
GO:0007507 | heart development | 0.000255872021783747 |
GO:0001707 | mesoderm formation | 0.000336138365925494 |
GO:0006915 | apoptosis | 0.000336138365925494 |
GO:0012501 | programmed cell death | 0.000340740012340497 |
GO:0048332 | mesoderm morphogenesis | 0.000340740012340497 |
GO:0001704 | formation of primary germ layer | 0.000357419631033899 |
GO:0008219 | cell death | 0.000365174092335362 |
GO:0016265 | death | 0.000365174092335362 |
GO:0043009 | chordate embryonic development | 0.000420508607951796 |
GO:0009792 | embryonic development ending in birth or egg hatching | 0.000420508607951796 |
GO:0001657 | ureteric bud development | 0.000420508607951796 |
GO:0014032 | neural crest cell development | 0.000420508607951796 |
GO:0014033 | neural crest cell differentiation | 0.000420508607951796 |
GO:0035150 | regulation of tube size | 0.000443745652675687 |
GO:0050880 | regulation of blood vessel size | 0.000443745652675687 |
GO:0003018 | vascular process in circulatory system | 0.000443745652675687 |
GO:0014031 | mesenchymal cell development | 0.000560669895248023 |
GO:0048762 | mesenchymal cell differentiation | 0.000560669895248023 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 0.000606857514252424 |
GO:0048869 | cellular developmental process | 0.000654571451121736 |
GO:0030154 | cell differentiation | 0.000654571451121736 |
GO:0003700 | transcription factor activity | 0.000654571451121736 |
GO:0001656 | metanephros development | 0.000676304752546427 |
GO:0007498 | mesoderm development | 0.000787634042924461 |
GO:0007219 | Notch signaling pathway | 0.000805111373058172 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.000841397142485504 |
GO:0006351 | transcription, DNA-dependent | 0.00087015276353609 |
GO:0032774 | RNA biosynthetic process | 0.00087015276353609 |
GO:0003677 | DNA binding | 0.000908457371142443 |
GO:0030198 | extracellular matrix organization and biogenesis | 0.00094426955727915 |
GO:0045449 | regulation of transcription | 0.00094426955727915 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00102050811980884 |
GO:0006350 | transcription | 0.00106294739370639 |
GO:0007369 | gastrulation | 0.00106294739370639 |
GO:0010468 | regulation of gene expression | 0.00121365013836572 |
GO:0042981 | regulation of apoptosis | 0.00121783817363992 |
GO:0043067 | regulation of programmed cell death | 0.00123766949604822 |
GO:0031323 | regulation of cellular metabolic process | 0.0014057899455575 |
GO:0048729 | tissue morphogenesis | 0.00142083030173103 |
GO:0043010 | camera-type eye development | 0.00142083030173103 |
GO:0003702 | RNA polymerase II transcription factor activity | 0.00143812190857447 |
GO:0007275 | multicellular organismal development | 0.00147269513102191 |
GO:0006916 | anti-apoptosis | 0.00147269513102191 |
GO:0032808 | lacrimal gland development | 0.00149196716771647 |
GO:0019222 | regulation of metabolic process | 0.00151457445837975 |
GO:0009653 | anatomical structure morphogenesis | 0.00154863928668225 |
GO:0016070 | RNA metabolic process | 0.00167038896588936 |
GO:0009790 | embryonic development | 0.00174998546026162 |
GO:0008283 | cell proliferation | 0.00190301382543278 |
GO:0001503 | ossification | 0.00190683017788915 |
GO:0031214 | biomineral formation | 0.0019166685748341 |
GO:0008015 | blood circulation | 0.0019166685748341 |
GO:0003013 | circulatory system process | 0.0019166685748341 |
GO:0043062 | extracellular structure organization and biogenesis | 0.00205577104252653 |
GO:0046849 | bone remodeling | 0.00217507082587939 |
GO:0009887 | organ morphogenesis | 0.00217507082587939 |
GO:0001654 | eye development | 0.00218859969867681 |
GO:0043283 | biopolymer metabolic process | 0.00221801486610398 |
GO:0048343 | paraxial mesodermal cell fate commitment | 0.00241990447998031 |
GO:0001946 | lymphangiogenesis | 0.00241990447998031 |
GO:0048342 | paraxial mesodermal cell differentiation | 0.00241990447998031 |
GO:0048513 | organ development | 0.00251199589922784 |
GO:0001701 | in utero embryonic development | 0.00267450316634048 |
GO:0048771 | tissue remodeling | 0.00273480680691769 |
GO:0010467 | gene expression | 0.00317181018120513 |
GO:0008475 | procollagen-lysine 5-dioxygenase activity | 0.00336735473890061 |
GO:0001710 | mesodermal cell fate commitment | 0.00336735473890061 |
GO:0048333 | mesodermal cell differentiation | 0.00336735473890061 |
GO:0003676 | nucleic acid binding | 0.00340510036640844 |
GO:0007399 | nervous system development | 0.00350202083618558 |
GO:0035239 | tube morphogenesis | 0.0037545139877692 |
GO:0040008 | regulation of growth | 0.0037545139877692 |
GO:0032502 | developmental process | 0.0037959290179612 |
GO:0048703 | embryonic viscerocranium morphogenesis | 0.00422756924733131 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 0.00441338829450723 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0045199112998873 |
GO:0048731 | system development | 0.00479757132385624 |
GO:0048514 | blood vessel morphogenesis | 0.0048250074971598 |
GO:0031490 | chromatin DNA binding | 0.00503898223525757 |
GO:0001501 | skeletal development | 0.00512211383636323 |
GO:0007420 | brain development | 0.00530039310425389 |
GO:0007423 | sensory organ development | 0.00531788971464045 |
GO:0048646 | anatomical structure formation | 0.00531788971464045 |
GO:0008354 | germ cell migration | 0.00572541466457373 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 0.00572541466457373 |
GO:0050794 | regulation of cellular process | 0.00572541466457373 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.00574991485824074 |
GO:0048598 | embryonic morphogenesis | 0.00588061462113732 |
GO:0035295 | tube development | 0.00588061462113732 |
GO:0001568 | blood vessel development | 0.00594593140978722 |
GO:0001944 | vasculature development | 0.00606904610846606 |
GO:0048523 | negative regulation of cellular process | 0.00643221661462505 |
GO:0048856 | anatomical structure development | 0.00741495559696795 |
GO:0007417 | central nervous system development | 0.00741495559696795 |
GO:0043170 | macromolecule metabolic process | 0.00741495559696795 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.00758778392991316 |
GO:0048519 | negative regulation of biological process | 0.00758778392991316 |
GO:0050789 | regulation of biological process | 0.00855235929487186 |
GO:0048704 | embryonic skeletal morphogenesis | 0.00927195405056161 |
GO:0030901 | midbrain development | 0.00927195405056161 |
GO:0016477 | cell migration | 0.00973041177184383 |
GO:0009888 | tissue development | 0.0101390133189321 |
GO:0045941 | positive regulation of transcription | 0.0101390133189321 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0104863220917352 |
GO:0035272 | exocrine system development | 0.0113547456293787 |
GO:0065007 | biological regulation | 0.0125701239648157 |
GO:0009725 | response to hormone stimulus | 0.0126885163954944 |
GO:0048706 | embryonic skeletal development | 0.0126885163954944 |
GO:0006928 | cell motility | 0.0127059919028333 |
GO:0051674 | localization of cell | 0.0127059919028333 |
GO:0005634 | nucleus | 0.0133156809330556 |
GO:0032501 | multicellular organismal process | 0.0135623576584384 |
GO:0001541 | ovarian follicle development | 0.0137674292428574 |
GO:0031325 | positive regulation of cellular metabolic process | 0.0140356843231172 |
GO:0044238 | primary metabolic process | 0.0140356843231172 |
GO:0006022 | aminoglycan metabolic process | 0.0140356843231172 |
GO:0030203 | glycosaminoglycan metabolic process | 0.0140356843231172 |
GO:0031418 | L-ascorbic acid binding | 0.0140356843231172 |
GO:0044237 | cellular metabolic process | 0.0142132735767427 |
GO:0043231 | intracellular membrane-bound organelle | 0.0145660465564809 |
GO:0043227 | membrane-bound organelle | 0.0145660465564809 |
GO:0009893 | positive regulation of metabolic process | 0.0149727271035296 |
GO:0001569 | patterning of blood vessels | 0.0157094986923561 |
GO:0048705 | skeletal morphogenesis | 0.0163135424484417 |
GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 0.0174975588847288 |
GO:0008286 | insulin receptor signaling pathway | 0.0174975588847288 |
GO:0005667 | transcription factor complex | 0.0184482272073624 |
GO:0030509 | BMP signaling pathway | 0.0198986971425132 |
GO:0022601 | menstrual cycle phase | 0.0198986971425132 |
GO:0022602 | menstrual cycle process | 0.0204520341561944 |
GO:0008585 | female gonad development | 0.0236921077603396 |
GO:0046660 | female sex differentiation | 0.0240642194559199 |
GO:0046545 | development of primary female sexual characteristics | 0.0240642194559199 |
GO:0009880 | embryonic pattern specification | 0.0261971158750841 |
GO:0042698 | menstrual cycle | 0.0261971158750841 |
GO:0043229 | intracellular organelle | 0.0261971158750841 |
GO:0043226 | organelle | 0.0261971158750841 |
GO:0044451 | nucleoplasm part | 0.0264031601890037 |
GO:0005654 | nucleoplasm | 0.028695203783531 |
GO:0043566 | structure-specific DNA binding | 0.0306960714670178 |
GO:0008632 | apoptotic program | 0.0311461302958456 |
GO:0008406 | gonad development | 0.032217241520755 |
GO:0048608 | reproductive structure development | 0.0332750766735975 |
GO:0065008 | regulation of biological quality | 0.0343796788979883 |
GO:0045137 | development of primary sexual characteristics | 0.0357606165460643 |
GO:0048754 | branching morphogenesis of a tube | 0.0357606165460643 |
GO:0051213 | dioxygenase activity | 0.0359602319518678 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 0.0359602319518678 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 0.036358308862171 |
GO:0031981 | nuclear lumen | 0.0373187989706492 |
GO:0001763 | morphogenesis of a branching structure | 0.0373187989706492 |
GO:0030326 | embryonic limb morphogenesis | 0.0373187989706492 |
GO:0035113 | embryonic appendage morphogenesis | 0.0373187989706492 |
GO:0048609 | reproductive process in a multicellular organism | 0.0415459412171078 |
GO:0032504 | multicellular organism reproduction | 0.0415459412171078 |
GO:0007548 | sex differentiation | 0.0424714038642085 |
GO:0048732 | gland development | 0.0428147060306397 |
GO:0048522 | positive regulation of cellular process | 0.0432596892398072 |
GO:0035107 | appendage morphogenesis | 0.0432596892398072 |
GO:0035108 | limb morphogenesis | 0.0432596892398072 |
GO:0007165 | signal transduction | 0.0433399854871231 |
GO:0043233 | organelle lumen | 0.0433399854871231 |
GO:0031974 | membrane-enclosed lumen | 0.0433399854871231 |
GO:0060173 | limb development | 0.0433399854871231 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.0433399854871231 |
GO:0048736 | appendage development | 0.0433399854871231 |
GO:0007411 | axon guidance | 0.0433399854871231 |
GO:0004725 | protein tyrosine phosphatase activity | 0.0466500409963091 |
GO:0003006 | reproductive developmental process | 0.0466500409963091 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
structure with developmental contribution from neural crest | 2.71e-09 | 92 |
ecto-epithelium | 1.27e-07 | 73 |
neurectoderm | 3.82e-07 | 64 |
neural plate | 3.82e-07 | 64 |
presumptive neural plate | 3.82e-07 | 64 |
ectoderm-derived structure | 5.04e-07 | 95 |
ectoderm | 5.04e-07 | 95 |
presumptive ectoderm | 5.04e-07 | 95 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 1.57537 |
MA0004.1 | 0.879856 |
MA0006.1 | 0.186435 |
MA0007.1 | 0.316976 |
MA0009.1 | 0.743257 |
MA0014.1 | 0.919317 |
MA0017.1 | 0.207884 |
MA0019.1 | 0.567591 |
MA0024.1 | 0.70077 |
MA0025.1 | 0.971686 |
MA0027.1 | 2.37948 |
MA0028.1 | 0.567414 |
MA0029.1 | 0.679737 |
MA0030.1 | 0.686088 |
MA0031.1 | 0.651724 |
MA0038.1 | 0.462726 |
MA0040.1 | 0.755433 |
MA0041.1 | 0.263922 |
MA0042.1 | 0.252679 |
MA0043.1 | 0.837621 |
MA0046.1 | 0.778239 |
MA0048.1 | 1.17627 |
MA0050.1 | 0.365212 |
MA0051.1 | 0.471092 |
MA0052.1 | 0.76328 |
MA0055.1 | 1.79839 |
MA0056.1 | 0 |
MA0057.1 | 0.406124 |
MA0058.1 | 1.27846 |
MA0059.1 | 2.03293 |
MA0060.1 | 0.789184 |
MA0061.1 | 0.147394 |
MA0063.1 | 0 |
MA0066.1 | 0.452472 |
MA0067.1 | 1.08124 |
MA0068.1 | 0.187364 |
MA0069.1 | 0.76361 |
MA0070.1 | 2.97928 |
MA0071.1 | 0.364454 |
MA0072.1 | 0.745922 |
MA0073.1 | 0.0672071 |
MA0074.1 | 1.07546 |
MA0076.1 | 0.223625 |
MA0077.1 | 0.724865 |
MA0078.1 | 0.502121 |
MA0081.1 | 0.277253 |
MA0083.1 | 0.836845 |
MA0084.1 | 1.4063 |
MA0087.1 | 0.794721 |
MA0088.1 | 0.534411 |
MA0089.1 | 0 |
MA0090.1 | 0.299987 |
MA0091.1 | 0.342071 |
MA0092.1 | 0.812369 |
MA0093.1 | 0.58345 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.408523 |
MA0101.1 | 0.265031 |
MA0103.1 | 0.216742 |
MA0105.1 | 0.0759118 |
MA0106.1 | 0.509454 |
MA0107.1 | 0.211681 |
MA0108.2 | 0.589413 |
MA0109.1 | 0 |
MA0111.1 | 0.839864 |
MA0113.1 | 0.482899 |
MA0114.1 | 0.145642 |
MA0115.1 | 0.84036 |
MA0116.1 | 0.186271 |
MA0117.1 | 0.808813 |
MA0119.1 | 0.733279 |
MA0122.1 | 0.828211 |
MA0124.1 | 1.02871 |
MA0125.1 | 0.955734 |
MA0130.1 | 0 |
MA0131.1 | 2.36861 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.873285 |
MA0136.1 | 0.437601 |
MA0139.1 | 2.28235 |
MA0140.1 | 0.408417 |
MA0141.1 | 0.233109 |
MA0142.1 | 0.63775 |
MA0143.1 | 0.49828 |
MA0144.1 | 0.88666 |
MA0145.1 | 0.3137 |
MA0146.1 | 2.1827 |
MA0147.1 | 0.475899 |
MA0148.1 | 0.344843 |
MA0149.1 | 0.269772 |
MA0062.2 | 0.0791588 |
MA0035.2 | 0.412747 |
MA0039.2 | 0.35217 |
MA0138.2 | 0.555696 |
MA0002.2 | 0.105469 |
MA0137.2 | 0.652494 |
MA0104.2 | 0.369356 |
MA0047.2 | 0.46201 |
MA0112.2 | 0.133279 |
MA0065.2 | 0.133827 |
MA0150.1 | 0.316876 |
MA0151.1 | 0 |
MA0152.1 | 1.16826 |
MA0153.1 | 0.889592 |
MA0154.1 | 0.759699 |
MA0155.1 | 0.354827 |
MA0156.1 | 0.634231 |
MA0157.1 | 0.606944 |
MA0158.1 | 0 |
MA0159.1 | 0.495113 |
MA0160.1 | 0.918217 |
MA0161.1 | 0 |
MA0162.1 | 1.95903 |
MA0163.1 | 0.355774 |
MA0164.1 | 0.437937 |
MA0080.2 | 0.609443 |
MA0018.2 | 0.446948 |
MA0099.2 | 0.549696 |
MA0079.2 | 2.00278 |
MA0102.2 | 1.45844 |
MA0258.1 | 0.135621 |
MA0259.1 | 0.455671 |
MA0442.1 | 0 |